{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-041507","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2026-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.893285+00:00","generated_at":"2026-05-15T06:51:44.159041+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Theriva Biologics fails to convene special meeting due to lack of quorum; will call new meeting","bullets":["Special Meeting on April 9, 2026 lacked quorum; meeting could not convene.","Company will call new meeting to seek approval for issuance of up to 16,184,560 shares upon exercise of New Warrants.","Under Inducement Agreement dated Oct 16, 2025, company must continue calling meetings every 60 days until approval or warrants expire.","Stockholders will receive new proxy materials with date/time of adjourned meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-041507","json":"https://secwatch.observer/filing/0001104659-26-041507.json","markdown":"https://secwatch.observer/filing/0001104659-26-041507.md","text":"https://secwatch.observer/filing/0001104659-26-041507.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465926041507/0001104659-26-041507-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465926041507/tm2611468d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:51:44.159041+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}